Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome

Presse Medicale

Volumn 41, Issue 9 PART2, 2012, Pages

  Jonsson, Malin V ^a   Theander, Elke ^b   Jonsson, Roland ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

A20 GENE; CANCER CLASSIFICATION; CANCER RISK; DISEASE ASSOCIATION; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LARGE CELL LYMPHOMA; LYMPHANGIOGENESIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PRACTICE GUIDELINE; PREDICTION; PRIMARY SJOEGREN SYNDROME; SHORT SURVEY; SJOEGREN SYNDROME;

EID: 84865956818     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.05.025     Document Type: Short Survey

References (41)

1. Jonsson R., Vogelsang P., Volchenkov R., Espinosa A., Wahren-Herlenius M., Appel S. The complexity of Sjögren's syndrome: novel aspects on pathogenesis. Immunol Lett 2011, 141(1):1-9.
2. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61(6):554-558.
3. Shiboski S.C., Shiboski C.H., Criswell L.A., Baer A.N., Challacombe S., Lanfranchi H., et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort. Arthritis Care Res 2012, 64(4):475-487.
4. Bowman S.J., Ibrahim G.H., Holmes G., Hamburger J., Ainsworth J.R. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004, 33(1):39-43.
5. Göransson L.G., Haldorsen K., Brun J.G., Harboe E., Jonsson M.V., Skarstein K., et al. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scand J Rheumatol 2011, 40(3):221-224.
6. Talal N., Bunim J.J. The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964, 36:529-540.
7. Anderson L.G., Talal N. The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol 1972, 10(2):199-221.
8. Voulgarelis M., Dafni U.G., Isenberg D.A., Moutsopoulos H.M. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999, 42(8):1765-1772.
9. Theander E., Manthorpe R., Jacobsson L.T. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004, 50(4):1262-1269.
10. Kassan S.S., Thomas T.L., Moutsopoulos H.M., Hoover R., Kimberly R.P., Budman D.R., et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978, 89(6):888-892.
11. Zintzaras E., Voulgarelis M., Moutsopoulos H.M. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005, 165(20):2337-2344.
12. Kauppi M., Pukkala E., Isomaki H. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997, 8(2):201-204.
13. Pertovaara M., Pukkala E., Laippala P., Miettinen A., Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001, 60(5):467-472.
14. Lazarus M.N., Robinson D., Mak V., Moller H., Isenberg D.A. Incidence of cancer in a cohort of patients with primary Sjögren's syndrome. Rheumatology (Oxford) 2006, 45(8):1012-1015.
15. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L.T. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006, 65(6):796-803.
16. Zhang W., Feng S., Yan S., Zhao Y., Li M., Sun J., et al. Incidence of malignancy in primary Sjögren's syndrome in a Chinese cohort. Rheumatology (Oxford) 2010, 49(3):571-577.
17. Anderson L.A., Gadalla S., Morton L.M., Landgren O., Pfeiffer R., Warren J.L., et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009, 125(2):398-405.
18. Smedby K.E., Hjalgrim H., Askling J., Chang E.T., Gregersen H., Porwit-MacDonald A., et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006, 98(1):51-60.
19. Vasaitis L, Nordmark G, Askling J, Ekström-Smedby K, Backlin C, Rönnblom L. Diffuse large B-cell lymphoma. An underestimated subtype and cause of death in primary Sjögren's syndrome. [Abstract]. Presented at the 11th International Symposium on Sjögren's syndrome, Athens, Greece, 2011.
20. Pollard R.P., Pijpe J., Bootsma H., Spijkervet F.K., Kluin P.M., Roodenburg J.L., et al. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: a retrospective clinical study. J Rheumatol 2011, 38(10):2198-2208.
21. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002, 46(3):741-747.
22. Sutcliffe N., Inanc M., Speight P., Isenberg D. Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 1998, 28(2):80-87.
23. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009, 88(5):284-293.
24. Ramos-Casals M., Brito-Zeron P., Yague J., Akasbi M., Bautista R., Ruano M., et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome. Rheumatology (Oxford) 2005, 44(1):89-94.
25. Theander E., Vasaitis L., Baecklund E., Nordmark G., Warfvinge G., Liedholm R., et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011, 70(8):1363-1368.
26. Mariette X, Boudaoud S, Nocturne G, Lazure T, Nititam J, Taylor K. Germinal and somatic abnormalities of the A20 (TNFAIP3) gene support a two-hit hypothesis of lymphomagenesis in autoimmune diseases. [Abstract]. Presented at the 11th International Symposium on Sjögren's syndrome, Athens, Greece, 2011.
27. Nordmark G., Kristjansdottir G., Vasaitis L., Kvarnstöm M., Sjöwall C., Eriksson P., et al. Genetic variation in complement C3 is associated with lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011, 70(Suppl. 3):175.
28. Ansell P., Simpson J., Lightfoot T., Smith A., Kane E., Howell D., et al. Non-Hodgkin lymphoma and autoimmunity: does gender matter?. Int J Cancer 2011, 129(2):460-466.
29. Solans-Laque R., Lopez-Hernandez A., Bosch-Gil J.A., Palacios A., Campillo M., Vilardell-Tarres M. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 2011, 41(3):415-423.
30. Baecklund E., Iliadou A., Askling J., Ekbom A., Backlin C., Granath F., et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006, 54(3):692-701.
31. Seror R., Ravaud P., Bowman S.J., Baron G., Tzioufas A., Theander E., et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010, 69(6):1103-1109.
32. Szyszko E.A., Brokstad K.A., Øijordsbakken G., Jonsson M.V., Jonsson R., Skarstein K. Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 2011, 13(1):R2.
33. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182(6):3540-3547.
34. Jonsson M.V., Skarstein K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome. J Oral Pathol Med 2008, 37(9):515-521.
35. Bombardieri M., Barone F., Humby F., Kelly S., McGurk M., Morgan P., et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome. J Immunol 2007, 179(7):4929-4938.
36. Daridon C., Pers J.O., Devauchelle V., Martins-Carvalho C., Hutin P., Pennec Y.L., et al. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2006, 54(7):2280-2288.
37. Barone F., Bombardieri M., Manzo A., Blades M.C., Morgan P.R., Challacombe S.J., et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum 2005, 52(6):1773-1784.
38. Salomonsson S., Jonsson M.V., Skarstein K., Brokstad K.A., Hjelmström P., Wahren-Herlenius M., et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003, 48(11):3187-3201.
39. Vinuesa C.G., Sanz I., Cook M.C. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009, 9(12):845-857.
40. Youinou P., Devauchelle V., Pers J.O. Significance of B cells and B cell clonality in Sjögren's syndrome. Arthritis Rheum 2010, 62(9):2605-2610.
41. Bahler D.W., Miklos J.A., Swerdlow S.H. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood 1997, 89(9):3335-3344.